| Description |
1 online resource |
|
text file |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Cover; Pharmaceutical Freedom; Copyright; Contents; Acknowledgments; Introduction; 1. A Defense of Self-Medication; 1.1 Two Motivating Cases; 1.2 Patients Know Best; 1.3 Patient Expertise and Drug Choice; 1.4 Intimate Choices; 1.5 Anti-paternalism and Freedom to Choose; 1.6 Patient Protection; 1.7 Ignorance and Fraud; 1.8 Self-Medication and Unapproved Drugs; 1.9 Self-Medication and Prescription Drugs; 1.10 Conclusion; 2. Paternalism and Public Health; 2.1 Prohibition and Protection; 2.2 Soft Paternalism and Drug Regulation; 2.3 Children and Incompetent Adults |
|
2.4 Hard Paternalism and Drug Regulation2.5 The Health Effects of Approval Requirements; 2.6 The Health Effects of Prescription Policies; 2.7 The Regulatory Reversal Test; 2.8 Certification Versus Approval; 2.9 Conclusion; 3. Rethinking Prescription Requirements; 3.1 Deadly Drugs; 3.2 Recreational Drugs and Addiction; 3.3 Therapeutics; 3.4 Antibiotics; 3.5 The Case for OTC Enhancements; 3.6 Rethinking Non-Medical Use; 3.7 Public Health and Preventive Medication; 3.8 Conclusion; 4. Responsibility and Regulation; 4.1 How Regulation Kills; 4.2 Necessity and the Need to Test |
|
4.3 Non-Ideal and Ideal Theory4.4 The Risks of an Approval System; 4.5 The Risks of a Certification System; 4.6 Conclusion; 5. The Politics of Self-Medication; 5.1 Patient-Driven Development; 5.2 Disobedience and Distribution; 5.3 Civil Disobedience; 5.4 Protest and Activism; 5.5 Democratic Authority and Self-Medication; 5.6 Conclusion; 6. The Business of Medicine; 6.1 Single Standards for Industry; 6.2 Private Options and the Global Marketplace; 6.3 Drug Prices and Deregulation; 6.4 Lifesaving Innovation and Patents; 6.5 Patents and Prizes; 6.6 Patents and the Rights of Producers |
|
6.7 Conclusion7. Medical Autonomy and Modern Healthcare; 7.1 Markets and Medical Autonomy; 7.2 Pharmaceutical Marketing; 7.3 Off-Label Marketing; 7.4 Professional Ethics; 7.5 Torts and Product Liability; 7.6 Insurance and Social Costs; 7.7 Conclusion; 8. Conclusion; References; Index |
| Summary |
Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements. |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Drug accessibility -- Law and legislation.
|
|
Drug accessibility -- Law and legislation. |
|
Pharmacy -- Law and legislation.
|
|
Pharmacy -- Law and legislation. |
|
Medical laws and legislation.
|
|
Medical laws and legislation. |
| Genre/Form |
Electronic books.
|
| Other Form: |
Print version : 9780190684549 |
| ISBN |
9780190684570 (electronic book) |
|
0190684577 (electronic book) |
|
9780190684556 (electronic book) |
|
0190684550 (electronic book) |
|
0190684542 |
|
9780190684549 |
|
